Results 271 to 280 of about 84,403 (307)

Nonsteroidal anti-inflammatory drug toxicity

Current Opinion in Rheumatology, 1993
The nonsteroidal anti-inflammatory drugs continue to be a mainstay of therapy for patients with chronic pain and inflammation. Because large numbers of these drugs are prescribed, even the most unusual adverse reactions are not uncommon. During the past year several reviews have appeared on the problems of nonsteroidal anti-inflammatory drug-induced ...
openaire   +2 more sources

Chirality and Nonsteroidal Anti-Inflammatory Drugs

Drugs, 1996
The nonsteroidal anti-inflammatory drugs (NSAIDs) are of significant clinical importance and include congeners of many chemical classes, some of which incorporate an asymmetric or chiral carbon atom. With very few exceptions, chiral NSAIDs have been marketed for clinical use as racemates. However, it is apparent that differences, sometimes major, exist
openaire   +2 more sources

Nonsteroidal Anti-Inflammatory Drug Gastropathy

Gastrointestinal Endoscopy Clinics of North America, 1996
NSAID gastropathy is characterized by subepithelial hemorrhages, erosions, and ulcers. Approximately half of patients taking NSAIDs regularly have gastric erosions and 10% to 30% have gastric ulcers. Although gastric lesions are common at endoscopy, clinically significant problems are uncommon.
openaire   +2 more sources

Toxicity of Nonsteroidal Anti-inflammatory Drugs

Archives of Internal Medicine, 1987
The literature on toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) is confusing. Much of the data relied on by pharmaceutical companies and the Food and Drug Administration comes from so-called Phase Three Trials . These are double-blind, controlled trials, usually of relatively brief (three months or less) duration.
openaire   +2 more sources

Toxicities of the nonsteroidal anti-inflammatory drugs

Current Opinion in Rheumatology, 1992
There has been significant progress in defining the risks associated with the use of nonsteroidal anti-inflammatory drugs. There is now clear consensus that certain patient subsets are at an increased risk for gastroduodenal mucosal damage when those patients are treated with these drugs.
openaire   +2 more sources

Photosentivity to Nonsteroidal Anti‐inflammatory Drugs

International Journal of Dermatology, 1989
A, Figueinedo, E, Teixeira, A, Poiares-Baptista   +2 more
openaire   +2 more sources

Nonsteroidal Anti-Inflammatory Drug Risks

The Journal of the American Dental Association, 2020
Allan C, Jones, Parish P, Sedghizadeh
openaire   +2 more sources

Nonsteroidal anti-inflammatory drugs and the kidney

Current Opinion in Nephrology and Hypertension, 2001
T, Stürmer, M M, Elseviers, M E, De Broe   +2 more
openaire   +2 more sources

Interaction of nonsteroidal anti-inflammatory drugs with membranes: In vitro assessment and relevance for their biological actions

Progress in Lipid Research, 2013
Catarina Pereira-Leite, Claudia Nunes
exaly  

Nonsteroidal Anti-Inflammatory Drugs

2016
openaire   +1 more source